ARCHIMMUNE ARCHITECTING IMMUNO-ONCOLOGY SOLUTIONS
Live / Allowed — Published for opposition (as of 17 Feb 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 25 Aug 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99355960
- Mark type
- Design + words
- Filed
- 25 Aug 2025
- Published for opposition
- 17 Feb 2026
- Attorney of record
- Perry Gattegno
Goods and services
- Class 042 — Scientific and technological services: Consulting services in the field of biotechnology; Consulting services in the field of pharmaceutical research and development; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Biochemical research and development; Consulting services in the field of pharmacogenetics; Scientific research and development; Vaccine research and development; Pharmaceutical research and development
Owner
- Fosun Pharma USA Inc., Princeton, NJ, US
- Fosun Pharma USA Inc., Princeton, NJ, US
Prosecution history
- 17 Feb 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 17 Feb 2026 — PUBLISHED FOR OPPOSITION
- 11 Feb 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 21 Jan 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 16 Jan 2026 — ASSIGNED TO EXAMINER
- 15 Jan 2026 — NOTICE OF DESIGN SEARCH CODE E-MAILED
- 15 Jan 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 25 Aug 2025 — APPLICATION FILING RECEIPT MAILED
- 25 Aug 2025 — NEW APPLICATION ENTERED